Skip to main content

previous disabled Page of 13
and
  1. No Access

    Article

    Ethnic-specific genetic susceptibility loci for endometriosis in Taiwanese-Han population: a genome-wide association study

    Endometriosis is a common gynecological disorder affecting around 10% of reproductive-age women. Although many hypotheses were proposed, genetic alteration has been considered as one of the key factors promoti...

    Jim **n-Chyuan Sheu, Wei-Yong Lin, Ting-Yuan Liu in Journal of Human Genetics (2024)

  2. No Access

    Article

    Stable inhibition of choroidal neovascularization by adeno-associated virus 2/8-vectored bispecific molecules

    Neovascular age-related macular degeneration (nAMD) causes severe visual impairment. Pigment epithelium-derived factor (PEDF), soluble CD59 (sCD59), and soluble fms-like tyrosine kinase-1 (sFLT-1) are potentia...

    Tinghui Bai, Bohao Cui, Man **ng, Siyue Chen, Yanfang Zhu, Dongxue Lin in Gene Therapy (2024)

  3. No Access

    Article

    Characteristics of tandem repeat inheritance and sympathetic nerve involvement in GAA-FGF14 ataxia

    Intronic GAA repeat expansion ([GAA] ≥250) in FGF14 is associated with the late-onset neurodegenerative disorder, spinocerebellar ataxia 27B (SCA27B, GAA-FGF14 ataxia). We aim to determine the prevalence of the G...

    Ze-Hong Zheng, Chun-Yan Cao, Bi Cheng, Ru-Ying Yuan in Journal of Human Genetics (2024)

  4. Article

    Open Access

    Retinoic acid related orphan receptor α is a genetic modifier that rescues retinal degeneration in a mouse model of Stargardt disease and Dry AMD

    Degeneration of the macula is associated with several overlap** diseases including age-related macular degeneration (AMD) and Stargardt Disease (STGD). Mutations in ATP Binding Cassette Subfamily A Member 4 (AB...

    M. Akula, S. M. McNamee, Z. Love, N. Nasraty, N. P. M. Chan, M. Whalen in Gene Therapy (2024)

  5. Article

    Open Access

    Preclinical safety and biodistribution of CRISPR targeting SIV in non-human primates

    In this study, we demonstrate the safety and utility of CRISPR-Cas9 gene editing technology for in vivo editing of proviral DNA in ART-treated, virally controlled simian immunodeficiency virus (SIV) infected r...

    Tricia H. Burdo, Chen Chen, Rafal Kaminski, Ilker K. Sariyer in Gene Therapy (2024)

  6. No Access

    Article

    CSTB gene replacement improves neuroinflammation, neurodegeneration and ataxia in murine type 1 progressive myoclonus epilepsy

    EPM1 is the most common form of Progressive Myoclonus Epilepsy characterized by late-childhood onset, ever-worsening and disabling myoclonus, seizures, ataxia, psychiatric disease, and shortened lifespan. EPM1...

    Emrah Gumusgoz, Sahba Kasiri, Mayank Verma, Jun Wu, Daniel Villarreal Acha in Gene Therapy (2024)

  7. Article

    Open Access

    A multinational survey of potential participant perspectives on ocular gene therapy

    Amidst rapid advancements in ocular gene therapy, understanding patient perspectives is crucial for sha** future treatment choices and research directions. This international cross-sectional survey evaluated...

    Alexis Ceecee Britten-Jones, Myra B. McGuinness, Fred K. Chen in Gene Therapy (2024)

  8. Article

    Retraction Note: Long noncoding RNA RBMS3-AS3 acts as a microRNA-4534 sponge to inhibit the progression of prostate cancer by upregulating VASH1

    Zhenming Jiang, Yuxi Zhang, ** Chen, **eng Wu, Dong Chen in Gene Therapy (2024)

  9. Article

    Open Access

    Correction: Preclinical safety and biodistribution of CRISPR targeting SIV in non-human primates

    Tricia H. Burdo, Chen Chen, Rafal Kaminski, Ilker K. Sariyer in Gene Therapy (2024)

  10. Article

    Open Access

    Successes and challenges in clinical gene therapy

    Despite the ups and downs in the field over three decades, the science of gene therapy has continued to advance and provide enduring treatments for increasing number of diseases. There are active clinical tria...

    Donald B. Kohn, Yvonne Y. Chen, Melissa J. Spencer in Gene Therapy (2023)

  11. No Access

    Article

    Suppression of bone metastatic castration-resistant prostate cancer cell growth by a suicide gene delivered by JC polyomavirus-like particles

    Prostate cancer is one of the most common cancers in men. The heterogeneity and mutations exhibited by prostate cancer cells often results in the progression to incurable metastatic castration-resistant prosta...

    Cheng-Huang Shen, Mien-Chun Lin, Chiung-Yao Fang, Pei-Lain Chen in Gene Therapy (2023)

  12. No Access

    Article

    Distinct functions of CAR-T cells possessing a dectin-1 intracellular signaling domain

    Chimeric antigen receptor T (CAR-T) cell therapy has demonstrated remarkable efficacies in treating hematopoietic malignancies, but not in the solid tumors. Incorporating costimulatory signaling domains, such ...

    **ao Liang, Yong Huang, Dan Li, **ao Yang, Lin Jiang, Weilin Zhou in Gene Therapy (2023)

  13. No Access

    Article

    Immune profiling of adeno-associated virus response identifies B cell-specific targets that enable vector re-administration in mice

    Adeno-associated virus (AAV) vector-based gene therapies can be applied to a wide range of diseases. AAV expression can last for months to years, but vector re-administration may be necessary to achieve life-l...

    Maria Chen, Boram Kim, Maria I. Jarvis, Samantha Fleury, Shuyun Deng in Gene Therapy (2023)

  14. Article

    In vivo genome editing using novel AAV-PHP variants rescues motor function deficits and extends survival in a SOD1-ALS mouse model

    CRISPR-based gene editing technology represents a promising approach to deliver therapies for inherited disorders, including amyotrophic lateral sclerosis (ALS). Toxic gain-of-function superoxide dismutase 1 (...

    Yi A. Chen, Mark W. Kankel, Sam Hana, Shukkwan Kelly Lau in Gene Therapy (2023)

  15. Article

    Open Access

    Survey of perspectives of people with inherited retinal diseases on ocular gene therapy in Australia

    Many gene therapies are in development for treating people with inherited retinal diseases (IRD). We hypothesized that potential recipients of gene therapy would have knowledge gaps regarding treatment. We aim...

    Heather G. Mack, Alexis Ceecee Britten-Jones, Myra B. McGuinness in Gene Therapy (2023)

  16. No Access

    Article

    Two high-fidelity variants: efSaCas9 and SaCas9-HF, which one is better?

    CRISPR/Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated endonuclease Cas9) nucleases have been widely applied for genome engineering. Staphylococcus aureus Cas9 (SaCas9) is com...

    **eng Lv, Haitao **, **ujuan Lv, Yue Zhou, Jiahua Wang, Haoran Chen in Gene Therapy (2022)

  17. No Access

    Article

    Genome editing using CRISPR/Cas9 to treat hereditary hematological disorders

    The clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9 (CRISPR/Cas9) system is a versatile and convenient genome-editing tool with prospects in gene therapy. This technique i...

    Yan Chen, Ruiting Wen, Zhigang Yang, Zhanghui Chen in Gene Therapy (2022)

  18. No Access

    Article

    Overexpression of miR-144-3p alleviates polycystic ovaries syndrome through targeting expression of HSP-70

    Increasing microRNAs are shown to be participate in polycystic ovarian syndrome (PCOS) pathogenesis. Nevertheless, the biological effects of miR-144-3p and its detailed mechanisms in PCOS are to be investigate...

    Bing Qu, Qinghong Zhao, Qinglian Ma, Tian Yang, Xueyao Li, Yu Chen in Gene Therapy (2022)

  19. No Access

    Article

    Effects of oncolytic viruses and viral vectors on immunity in glioblastoma

    Glioblastoma (GBM) is regarded as an incurable disease due to its poor prognosis and limited treatment options. Virotherapies were once utilized on cancers for their oncolytic effects. And they are being reviv...

    Penghao Liu, Yaning Wang, Yuekun Wang, Ziren Kong, Wanqi Chen, Jiatong Li in Gene Therapy (2022)

  20. Article

    Open Access

    AAV1.NT-3 gene therapy for X-linked Charcot–Marie–Tooth neuropathy type 1

    X-linked Charcot-Marie-Tooth neuropathy (CMTX) is caused by mutations in the gene encoding Gap Junction Protein Beta-1 (GJB1)/Connexin32 (Cx32) in Schwann cells. Neurotrophin-3 (NT-3) is an important autocrine...

    Burcak Ozes, Morgan Myers, Kyle Moss, Jennifer Mckinney, Alicia Ridgley in Gene Therapy (2022)

previous disabled Page of 13